Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy

Bobbo, Marco; Pinamonti, Bruno; Merlo, Marco; Stolfo, Davide; Iorio, Annamaria; Ramani, Federica; Barbati, Giulia; Carriere, Cosimo; Massa, Laura; Poli, Stefano; Scapol, Sara; Gigli, Marta; Lenarda, Andrea Di; Sinagra, Gianfranco

doi:10.1016/j.amjcard.2016.10.014

Cited by 14 publications

(8 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, it is clear that the risk of ventricular arrhythmia varies according to aetiology. For example, it has been reported that patients with DCM secondary to systemic hypertension (usually older and with more co‐morbidities) have lower arrhythmic event rates during follow‐up . Conversely, younger patients with some of the more malignant genetic forms of DCM may have a greater survival benefit from ICD implantation …”

Section: Specific Aspects In the Clinical Management Of Dilated Cardimentioning

confidence: 99%

“…For example, it has been reported that patients with DCM secondary to systemic hypertension (usually older and with more co-morbidities) have lower arrhythmic event rates during follow-up. 49 Conversely, younger patients with some of the more malignant genetic forms of DCM may have a greater survival benefit from ICD implantation. 5,47,48 In addition, only one-third of DCM cases admitted with current criteria for ICD still fulfill indications for implantation 6 months after initiation of optimal medical treatment.…”

Section: Arrhythmic Risk Stratificationmentioning

confidence: 99%

See 1 more Smart Citation

Evolving concepts in dilated cardiomyopathy

Merlo

Cannatà

Gobbo

et al. 2017

European J of Heart Fail

Self Cite

279

270

View full text Add to dashboard Cite

Dilated cardiomyopathy (DCM) represents a particular aetiology of systolic heart failure that frequently has a genetic background and usually affects young patients with few co-morbidities. The prognosis of DCM has improved substantially during the last decades due to more accurate aetiological characterization, the red-flag integrated approach to the disease, early diagnosis through systematic familial screening, and the concept of DCM as a dynamic disease requiring constant optimization of medical and non-pharmacological evidence-based treatments. However, some important issues in clinical management remain unresolved, including the role of cardiac magnetic resonance for diagnosis and risk categorization and the interaction between genotype and clinical phenotype, and arrhythmic risk stratification. This review offers a comprehensive survey of these and other emerging issues in the clinical management of DCM, providing where possible practical recommendations.

show abstract

Section: Specific Aspects In the Clinical Management Of Dilated Cardimentioning

confidence: 99%

Section: Arrhythmic Risk Stratificationmentioning

confidence: 99%

Evolving concepts in dilated cardiomyopathy

Merlo

Cannatà

Gobbo

et al. 2017

European J of Heart Fail

Self Cite

279

270

View full text Add to dashboard Cite

show abstract

“…Moreover, the lower prevalence of comorbidities when compared to most patients with other forms of systolic LV dysfunction suggests that individuals with DCM tend to have fewer non-cardiovascular events [25]. In hypertensive heart disease, for example, there is a lower incidence of arrhythmic events and a greater competitive risk of non-cardiovascular events [28].…”

Section: Natural Historymentioning

confidence: 99%

Clinical Presentation, Spectrum of Disease, and Natural History

Merlo

Stolfo

Caiffa

et al. 2019

Dilated Cardiomyopathy

Self Cite

View full text Add to dashboard Cite

“…"Red flags" echocardiographic clues can raise the suspicion of a diagnosis but are however not totally specific for a definitive etiology. For example, documentation of LV dysfunction, not necessarily associated with LV hypertrophy, in patients with history of systemic hypertension may clarify the cause of LV dysfunction as endstage dilated and hypokinetic phase of hypertensive heart disease that may mimic a DCM [82]. Also multivessel coronary heart disease can be indistinguishable by echocardiography from DCM, and sometimes only coronary angiography clarifies the diagnosis.…”

Section: Clinical Echocardiography In Dcm: Advantages and Limitationsmentioning

confidence: 99%